1.B-cell translocation gene 2 positively regulates GLP-1-stimulated insulin secretion via induction of PDX-1 in pancreatic beta-cells.
Seung Lark HWANG ; Okyun KWON ; Sun Gyun KIM ; In Kyu LEE ; Yong Deuk KIM
Experimental & Molecular Medicine 2013;45(5):e25-
Glucagon-like peptide-1 (GLP-1) is a potent glucoincretin hormone and an important agent for the treatment of type 2 diabetes. Here we demonstrate that B-cell translocation gene 2 (BTG2) is a crucial regulator in GLP-1-induced insulin gene expression and insulin secretion via upregulation of pancreatic duodenal homeobox-1 (PDX-1) in pancreatic beta-cells. GLP-1 treatment significantly increased BTG2, PDX-1 and insulin gene expression in pancreatic beta-cells. Notably, adenovirus-mediated overexpression of BTG2 significantly elevated insulin secretion, as well as insulin and PDX-1 gene expression. Physical interaction studies showed that BTG2 is associated with increased PDX-1 occupancy on the insulin gene promoter via a direct interaction with PDX-1. Exendin-4 (Ex-4), a GLP-1 agonist, and GLP-1 in pancreatic beta-cells increased insulin secretion through the BTG2-PDX-1-insulin pathway, which was blocked by endogenous BTG2 knockdown using a BTG2 small interfering RNA knockdown system. Finally, we revealed that Ex-4 and GLP-1 significantly elevated insulin secretion via upregulation of the BTG2-PDX-1 axis in pancreatic islets, and this phenomenon was abolished by endogenous BTG2 knockdown. Collectively, our current study provides a novel molecular mechanism by which GLP-1 positively regulates insulin gene expression via BTG2, suggesting that BTG2 has a key function in insulin secretion in pancreatic beta-cells.
Animals
;
Gene Expression Regulation/drug effects
;
Glucagon-Like Peptide 1/*pharmacology
;
Homeodomain Proteins/*genetics/metabolism
;
Humans
;
Immediate-Early Proteins/genetics/*metabolism
;
Insulin/genetics/*secretion
;
Insulin-Secreting Cells/drug effects/*metabolism
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Peptides/pharmacology
;
Promoter Regions, Genetic/genetics
;
Protein Binding/drug effects/genetics
;
Rats
;
Trans-Activators/*genetics/metabolism
;
Tumor Suppressor Proteins/genetics/*metabolism
;
Venoms/pharmacology
2.Britanin Suppresses IgE/Ag-Induced Mast Cell Activation by Inhibiting the Syk Pathway.
Yue LU ; Xian LI ; Young Na PARK ; Okyun KWON ; Donggen PIAO ; Young Chae CHANG ; Cheorl Ho KIM ; Eunkyung LEE ; Jong Keun SON ; Hyeun Wook CHANG
Biomolecules & Therapeutics 2014;22(3):193-199
The aim of this study was to determine whether britanin, isolated from the flowers of Inula japonica (Inulae Flos), modulates the generation of allergic inflammatory mediators in activated mast cells. To understand the biological activity of britanin, the authors investigated its effects on the generation of prostaglandin D2 (PGD2), leukotriene C4 (LTC4), and degranulation in IgE/Ag-induced bone marrow-derived mast cells (BMMCs). Britanin dose dependently inhibited degranulation and the generations of PGD2 and LTC4 in BMMCs. Biochemical analyses of IgE/Ag-mediated signaling pathways demonstrated that britanin suppressed the phosphorylation of Syk kinase and multiple downstream signaling processes, including phospholipase Cgamma1 (PLCgamma1)-mediated calcium influx, the activation of mitogen-activated protein kinases (MAPKs; extracellular signal-regulated kinase 1/2, c-Jun NH2-terminal kinase and p38), and the nuclear factor-kappaB (NF-kappaB) pathway. Taken together, the findings of this study suggest britanin suppresses degranulation and eicosanoid generation by inhibiting the Syk-dependent pathway and britanin might be useful for the treatment of allergic inflammatory diseases.
Calcium
;
Family Characteristics
;
Flowers
;
Inula
;
Leukotriene C4
;
Mast Cells*
;
Mitogen-Activated Protein Kinases
;
Phospholipases
;
Phosphorylation
;
Phosphotransferases
;
Prostaglandin D2